G'day Jaggin, maybe this is a rose coloured glasses thing but I actually find the disclosure quite positive and in line with the way that Baker carries himself and this company - he's a straight shooter.
First the first time ever in the history of bio-spec companies you have these guys coming out and saying we're not happy with some technical issues associated with the contract research orgs in-mouse trials and that they want the trial to be repeated. Good on them. Good quality control and good science by my read.
G'day Jaggin, maybe this is a rose coloured glasses thing but I...
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $126.0M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 11.5¢ | $161.7K | 1.342M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 449634 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 774227 | 9 |
View Market Depth
| Last trade - 12.19pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
12.0¢ |
Change
0.005 ( 9.09 %) |
||||
| Open | High | Low | Volume | ||
| 12.0¢ | 12.5¢ | 12.0¢ | 485688 | ||
| Last updated 12.09pm 05/06/2024 ? | |||||
| ALA (ASX) Chart |